Precision Xtract is the global market access consultancy within Precision Value & Health, designed to deliver a full-service complement of science, strategy, tools, and tactics to support next-generation approaches to drug development and product value demonstration. With more than 100 employees in offices across the US, Canada, and Europe, we have successfully supported the global market access needs of hundreds of brands—and we have the proven expertise to support yours.
Cota Healthcare is a real-world data and analytics company that enables providers, payers and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. We do this using the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.
Cota's technology abstracts and enriches medical records to create research-grade data and joins it with a suite of analysis, visualization and management tools. This enables providers, payers and life science companies to analyze, report on and research outcomes, costs, treatments and quality at any granularity and stage of the patient journey. The analysis permits comparisons of clinically similar patient cohorts and their treatments and outcomes across physicians and sites of care. The clinical provider can evaluate/optimize treatment plans using multiple longitudinal outcome measures such as overall and progression-free survival, response to treatment, side effects, functional status and more. Cota's real-world evidence sets are being used by life science companies to expand the application of precise clinical data to broaden the efficacies and lower the costs of clinical trials.
Allscripts Payer & Life Sciences (PLS) organization is an integrated data, analytics and services company. PLS provides data-driven insights designed to improve healthcare outcomes by supporting providers, payers, and life sciences companies in their focus on the patient journey. The PLS portfolio includes clinical research alternatives, clinical workflow solutions, health plan offerings, best in class analytics, and industry-leading, cloud-based, electronic health records.
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. For more information, visit www.FoundationMedicine.com.
ZS is the world’s largest firm focused exclusively on helping companies improve overall performance and grow revenue and market share through end-to-end solutions—from customer insights and strategy, to analytics, to operations and technology. More than 5,000 ZS professionals in 22 offices worldwide draw on deep industry and domain expertise to deliver impact for clients across multiple industries. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn.
End-to-End Analytics is a consulting firm founded on the premise that most organizations struggle to take full advantage of the opportunities presented by their ever-increasing volume of data. End-to-End helps its clients make better data-driven decisions and solves complex business challenges by applying the appropriate balance of management consulting, analytics, and technology. We deliver actionable solutions to improve profitability, productivity, revenue, revenue prediction and asset and resource utilization.
Oshi Health is a startup digital health company, founded in 2018, that is revolutionizing the management and treatment of IBD. Oshi empowers people with IBD through tracking and education, and it will support IBD stakeholders within the healthcare community, including medical researchers, with data that enables new treatment advances and care optimization. The company is led by digital health veteran and CEO Daniel Weinstein, who previously co-founded Cohero Health, which is disrupting the care of asthma and COPD through its connected mobile platform. The company has raised a significant Series A round of funding led by a leading global healthcare company.
Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com.
Optum® is a health services and innovation company. We help life sciences companies leverage real-world evidence to improve their knowledge and understanding of market dynamics. Through these data and analytics, we help clients outline actionable insights to enable more efficient and effective commercialization strategies.
Based in New York City, Aetion is a leading health care technology company that delivers the real-world analytics and evidence needed for pharmaceutical developers and purchasers to thrive in value-based care. With its patented rapid-cycle analytics technology, the Aetion Evidence Platform uses the everyday clinical and financial interactions of the health care system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and a big data pioneer, Aetion enables biopharma companies and payers to collaborate in real-time to develop therapeutic insights so patients get the most clinically effective — and cost-effective — care. Learn more at www.aetion.com.
BERG is a clinical-stage, artificial intelligence-powered biotech leveraging its proprietary platform, Interrogative Biology®, to map disease and revolutionize treatments across oncology, Parkinson’s and rare diseases. BERG has leveraged Interrogative Biology® to develop a robust pipeline of first-in-class product candidates and diagnostics that advance bold innovations that have the potential to improve patient lives
RxDataScience, Inc. is a big data analytics software company focused on creating breakthrough data science products and solutions to deliver business value. We are applying proven advanced analytics, artificial intelligence, and machine learning technologies from industries such as financial services to drive innovation in pharmaceutical and healthcare industries. Our team is comprised of data science and software product development experts with deep knowledge of pharma and healthcare datasets and use cases.